To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Gina Columbus
The Food and Drug Administration has approved the NovoTTF-100L System in combination with pemetrexed and platinum-based chemotherapy for the front-line treatment of patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma.
Angelica Welch
An immunotherapy pair looks promising for those with pleural mesothelioma, which is now treated with chemotherapy.
Angelica Welch
Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.
Lauren M. Green
After a shocking diagnosis, Heather Von St. James is on a mission to spread awareness about mesothelioma. 
Silas Inman
Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.
Anita T. Shaffer
An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.
Charlotte Huff
Finding specialized care is worth the effort for patients with uncommon cancers.

Readers respond to past CURE articles on living with mesothelioma, hospice, beating bladder cancer, lung cancer, and response to CURE's 2007 Cancer Resource Guide.

Katy Human

Asbestos exposure is the main cause of mesothelioma, accounting for more than 80 percent of cases.


Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other